Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

NCT01681576 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Salt-sensitive Hypertension

Interventions

DRUG: Valsartan
DRUG: LCZ696

Sponsor

Novartis Pharmaceuticals